EN · на языке оригинала

Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns

Thinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.

FOX News Соединенные Штаты · 12 ноября 2026

Это отрывок. Полный текст статьи — на сайте FOX News.

Читать в источнике

Полный текст статьи на вашем языке
AI-сводка и перевод с оригинала
Тот же аккаунт работает в приложении Suviy

Войти

Бесплатно.

Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns

Комментарии

6-minute daily habit could help Ozempic users preserve muscle, expert says

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Common heart pill under scrutiny for older patients as study weighs risks of stopping

Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns

Полный текст, перевод и AI-сводка — после входа

Комментарии

Похожие материалы

6-minute daily habit could help Ozempic users preserve muscle, expert says

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Common heart pill under scrutiny for older patients as study weighs risks of stopping